Back to Search Start Over

LRFN2 gene variant rs2494938 provides susceptibility to esophageal cancer in the population of Jammu and Kashmir.

Authors :
Shah R
Sharma V
Singh H
Sharma I
Bhat GA
Shah IA
Iqbal B
Rafiq R
Nissa N
Muzaffar M
Rasool MT
Lone GN
Kaul S
Lone MM
Rai E
Dar NA
Sharma S
Source :
Journal of cancer research and therapeutics [J Cancer Res Ther] 2020 Dec; Vol. 16 (Supplement), pp. S156-S159.
Publication Year :
2020

Abstract

Background: Leucine-rich repeat and fibronectin type 2 gene (LRFN2) variant rs2494938 has recently been found associated with esophageal cancer in a genome-wide association study in an Asian population. However, this association has not been replicated in any Indian population despite high incidence of the disease.<br />Materials and Methods: In the present case-control study, 166 cases and 459 controls were included. Taqman assay technique using real-time PCR was employed to investigate the association of the variant with esophageal cancer in the population of Jammu and Kashmir (J&K). The Hardy-Weinberg equilibrium for rs2494938 was assessed using the Chi-square test. The allele- and genotype-specific risk was estimated by odds ratio (OR) with 95% confidence interval (CI).<br />Results: Variant rs2494938 was observed to be significantly associated with esophageal cancer with an allelic OR of 1.59 (1.23-2.04 at 95% CI, P = 0.0003).<br />Conclusion: The study highlights LRFN2 as a candidate gene for esophageal cancer susceptibility in the population of J&K and calls for a detailed study with a large sample size and involving more ethnic groups of India.<br />Competing Interests: None

Details

Language :
English
ISSN :
1998-4138
Volume :
16
Issue :
Supplement
Database :
MEDLINE
Journal :
Journal of cancer research and therapeutics
Publication Type :
Academic Journal
Accession number :
32880595
Full Text :
https://doi.org/10.4103/jcrt.JCRT_613_19